Hope Rugo
MD
Professor of Medicine, Director Breast Oncology Clinical Trials
👥Biography 个人简介
Hope Rugo at UCSF directs breast oncology clinical trials with expertise in novel targeted therapies for HR-positive disease. She was a key investigator in the CAPItello-291 trial of capivasertib plus fulvestrant, demonstrating improved outcomes in PIK3CA/AKT/PTEN-altered HR+ breast cancer. Her research encompasses CDK4/6 inhibitors, PI3K pathway agents, and antibody-drug conjugates for advanced breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hope Rugo 的研究动态
Follow Hope Rugo's research updates
留下邮箱，当我们发布与 Hope Rugo（UCSF Helen Diller Family Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment